BioPharm America 2014: Interview with Eric Halioua, Promethera Biosciences

July 7, 2015
Eric Halioua, CEO of Promethera Biosciences, speaks with partnering360:Insight on their cell therapy products to treat liver diseases affecting children and adults using allogeneic progenitor cells harvested from healthy human livers. Promethera is currently conducting a first multicentric Phase I/II clinical trial for the treatment of Crigler-Najjar syndrome and Urea Cycle Disorder in children. Find more videos and articles at http://www.partnering360.com/insight For more information on BioPharm America, visit our webpage: http://www.ebdgroup.com/bpa/index.php
Previous Video
BioPharm America 2014: Interview with Roger Pomerantz, Seres Health
BioPharm America 2014: Interview with Roger Pomerantz, Seres Health

Roger Pomerantz, President and CEO of Seres Health, a 2014 FierceBiotech Fierce 15 winning company, shares ...

Next Video
BioPharm America 2014: Interview with Annalisa Jenkins, Dimension Therapeutics
BioPharm America 2014: Interview with Annalisa Jenkins, Dimension Therapeutics

In an interview at BioPharm America 2014 in Boston on September 22, John Carroll, Editor-in-Chief of Fierce...